The effect of targeted rheumatoid arthritis therapeutics on systemic inflammation and anemia: analysis of data from the CorEvitas RA registry

BACKGROUND: To evaluate the effects of tumor necrosis factor inhibitors (TNFi), interleukin-6 receptor inhibitors (IL-6Ri), and Janus kinase inhibitors (JAKi) on hemoglobin (Hb) and C-reactive protein (CRP) levels in adults enrolled in CorEvitas (formerly Corrona), a large US rheumatoid arthritis (R...

Descripción completa

Detalles Bibliográficos
Autores principales: Padula, Anthony S., Pappas, Dimitrios A., Fiore, Stefano, Blachley, Taylor S., Ford, Kerri, Emeanuru, Kelechi, Kremer, Joel M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9769058/
https://www.ncbi.nlm.nih.gov/pubmed/36544236
http://dx.doi.org/10.1186/s13075-022-02955-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9769058/
https://www.ncbi.nlm.nih.gov/pubmed/36544236
http://dx.doi.org/10.1186/s13075-022-02955-y

Ejemplares similares